Abrdn Life Sciences Investors (HQL) revenue

Revenue · fiscal 2025
$86.39M

Abrdn Life Sciences Investors (HQL) reported revenue of $86.39M in fiscal 2025 (the year ended September 30, 2025). That is 0.3% lower than the $86.69M of fiscal 2024. Figures as of 18 Nov 2026, 12:06 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2025
$86.39M
Change on fiscal 2024
−0.3%
Highest on record
$86.69Mfiscal 2024
Lowest on record
-$103.25Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Abrdn Life Sciences Investors revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $86.69M in fiscal 2024 and the lowest -$103.25M in fiscal 2022.

History · 4 fiscal years

Revenue by fiscal year

Abrdn Life Sciences Investors revenue, year by year

Abrdn Life Sciences Investors (HQL) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$86.39M 0.3% down
2024$86.69M 268.5% up
2023$23.52M—
2022-$103.25M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on HQL

Abrdn Life Sciences Investors, figure by figure

Abrdn Life Sciences Investors (HQL) overview: price, valuation and scorecard

Abrdn Life Sciences Investors revenue: questions and answers

What is Abrdn Life Sciences Investors's revenue?

Abrdn Life Sciences Investors (HQL) reported revenue of $86.39M in fiscal 2025 (the year ended September 30, 2025). That is 0.3% lower than the $86.69M of fiscal 2024.

What are the highest and lowest revenue figures on record for Abrdn Life Sciences Investors?

Across the 4 fiscal years on record (2022–2025), the highest was $86.69M in fiscal 2024 and the lowest -$103.25M in fiscal 2022.

How is Abrdn Life Sciences Investors's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Abrdn Life Sciences Investors it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Abrdn Life Sciences Investors (HQL) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/HQL/revenue

Underlying data: Yahoo Finance.